Preeclampsia is not just a complication of pregnancy
Authors:
L. Greiffeneggová 1,2; D. Hrubá 1; P. Kaňová 1
Authors place of work:
Ústav ochrany a podpory zdraví LF MU, Brno, Přednostka: prof. MUDr. Zuzana Derflerová Brázdová, DrSc.
1; Katedra porodní asistence a zdravotnických záchranářů LF MU, Brno
Přednosta: doc. MUDr. Igor Crha, CSc.
2
Published in the journal:
Prakt. Lék. 2017; 97(3): 117-122
Category:
Of different specialties
Summary
The evidence that women with preeclamptic complications during pregnancy are at increased risk of cardiovascular and renal diseases later in life is accumulated in the past decades. There is no standardised follow-up to these women, although their early identification followed by both primary and secondary prevention and treatment can reduce the potential incidence of cardiovascular diseases and severe renal failures.
It is necessary to create the multidisciplinary evidence-based guidelines for the screening of vulnerable women and their offspring and for the risk management.
Keywords:
preeclampsia – cardiovascular risk – renal failure – standardized management of care – multidisciplinary approach
Zdroje
1. Abalas E, Cuesta C, Grosso AJ, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2013; 170(1): 1–7. http://dx.doi.org/10.1016/j.ejogrb.2013.05.005
2. Agatisa PK, Ness RB, Roberts JM, et al. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 2004; 286: H1389–H1393.
3. Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta analysis. BMJ 2007; 335: 974.
4. Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol 1999; 181: 1026–1035.
5. von Dadaelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003; 22(2): 143–148.
6. McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia /eclampsia: A systematic review and meta analyses. Am Heart J 2008; 156: 918–930.
7. Drost JT, Maas AHEM, Hlewijn S, et al. Novel cardiovascular biomarkers in women with history of early preeclampsia. Atherosclerosis 2014; 237: 117–122.
8. Duckitt K, Harrington D. Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 333: 330–365.
9. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130–137.
10. Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology 2005; 16(2): 206–215.
11. Halland F, deRoo L, Morken NH, et al. Association of women’s reproductive history with long-term mortality and effect of socioeconomic factors. Obstet Gynecol 2015; 126: 1181–1187.
12. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997; 77: 154–158.
13. Heida K, Bots ML, de Groot CJ, et al. Cardiovascular risk management after reproductive and pregnancy related disorders: A Dutch multidisciplinary evidence-based guidelines. Eur J Prev Cardiol 2016; 23(17): 1863–1879.
14. Hunt P. Maternal health and human rights. Lancet 2008; 371: 203–204.
15. Jayet PY, Rimoldi SF, Stuber T, et al. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation 2010; 122: 488–494.
16. Kaaja R, Kinnunen T, Luoto R. Regional differences in the prevalence of pre-eclampsia in relation to the risk factors for coronary artery disease in women in Finland. Eur Heart J 2005; 26: 44–50.
17. Kajantie E, Eriksson JG, Osmond C, et al. Preeclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009; 40: 1176–1180.
18. Kvehaugen AS, Dechend R, Ramstad HB, et al. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension 2011; 58: 63–69.
19. Loset M, Johnson MP, Melton PE, et al. Preeclampsia and cardiovascular disease share genetic risk factors on chromosome 2q22. Pregnancy Hypertens 2014; 4: 178–185.
20. Lykke JA, Langhoff-Roos J, Sibai BM, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53: 944–951.
21. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the Child Health and Development Studies Cohort. Hypertension 2010; 56: 166–171.
22. Nováková L. Jaká je hodnota testů na preeklampsii? Labor Aktuell 2016; 3: 24–27.
23. Paauw ND, Luijken K, Franx A, et al. Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention. Clin Sci (Lond) 2016; 130(4): 239–246.
24. Pell JP, Smith GC, Walsh D. Pregnancy complications and subsequent maternal cerebrovascular events: a retrospective cohort study of 119.668 births. Am J Epidemiol 2004; 159: 336–342.
25. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia: a disease of the maternal endothelium. The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123: 2856–2869.
26. Powers RW, Roberts JM, Cooper KM, et al. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am J Obstet Gynecol 2005; 193: 185–191.
27. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes. CHAMPS: population-based retrospective cohort study. Lancet 2005; 366: 1797–1803.
28. van Rijn BB, Veerbeek JH, Scholtens LC, et al. C-reactive protein and fibrinogen levels as determinants of reccurent preeclampsia: a prospective cohort study. J Hypertension 2014; 32: 408–414.
29. Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E: to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010; 362: 1282–1291.
30. Roberts ChL, Ford JB, Algert ChS, et al. Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open 2011; 1: e000101. doi 10.1136/bmjopen-2011-000101
31. Signore C, Mills JL, Qian C, et al. Circulating angiogenic factors and placental abruption. Prenat Diagn 2008; 28: 852–858.
32. Spratling PM, Pryor ER, Moneyham LD, et al. Effect of educational intervention on cardiovascular disease risk perception among women with preeclampsia. J Obstet Gynecol Neonatal Nurs 2014; 43: 179–189.
33. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129.290 births. Lancet 2001; 357: 2002–2006.
34. Smith GN, Pudwell J, Walker M, Shi-Wu Wen. Ten-year, thirty-year and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeklampsia. J Obstet Gynaecol Can 2012; 34(9): 830–835.
35. Staff AC, Redman ChWG, Williams D, et al. Pregnancy and long-term maternal cardiovascular Health. Progress through harmonization of research cohorts and biobanks. Hypertension 2016; 67: 251–260. doi:10.1161/hypertensionaha.115.06.357
36. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007; 18: 2281–2284.
37. Thadhani R. Ecker JL, Kettyle F, et al. Pulse pressure and risk of preeclampsia: s prospective study. Obstet Gynecol 2001; 97: 515–520.
38. Vatten LJ, Romundstad PR, Holmen TL, et al. Intreuterine exposure to preeclampsia and adolescent blood pressure, body size and age at menarche in female offsprings. Obstet Gynecol 2003; 101: 529–533.
39. Veerbeek JHW, Hermes W, Breimer AY, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia and pregnancy-induced hypertension. Hypertension 2015; 65: 600–606.
40. Vikse BE, Irgens LM, Leivestad T, et al. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008; 359: 800–809.
41. Wang JX, Knottnerus AM, Schuit G, et al. Surgically obtained sperm, and risk of gestational hypertension and preeclampsia. Lancet 2002; 359: 673–674.
42. White WM, Mielke MM, Araoz PA, et al. A history of preeclampsia is associated with a risk for coronary artery calcification 3 decades later. Am J Obstet Gynecol 2016; 214(4): 519.e1-8.
43. Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life from cohort study. BMJ 2003; 326(7394): 845.
44. Young B, Hacker M, Rana S. Physicians’´ knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy 2012; 31: 50–58.
45. Zhou Y, Damsky Ch, Roberts JM, et al. Preeclampsia is associated with abnormal expression of adhession molecules by invasive cytotrophoblast. J Clin Invest 1993; 91: 950–960.
46. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associate with failure of human cytotrophoblast to mimic a vascular adhesion phenotype: on a cause of defective endovascular invasion in this syndrome? J Clin Invest 1997; 99: 2152–2164.
Štítky
General practitioner for children and adolescents General practitioner for adultsČlánok vyšiel v časopise
General Practitioner
2017 Číslo 3
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine Eases Daily Life for Patients and Caregivers
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
Najčítanejšie v tomto čísle
- Preeclampsia is not just a complication of pregnancy
- Drug combinations in the treatment of obesity: the past and present
- Patient-centered care: general aspects and terminology challenges
- The selected indicators of health status of the Czech population – results of EHES study 2014